United States · Platforms & data · Stocktwits

Novo CEO Brushes Off Post-Midterm Drug-Pricing Fears, Says ‘Our World’ Won’t Change Dramatically – NVO Stock Gains Pre-Market

Published by Stocktwits · United States 12 h ago

CEO Mike Doustdar told CNBC that while the company has experienced weak growth in the past due to pricing, volumes have grown ‘phenomenally.’ ...

Read the full article on Stocktwits Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)

Also worth reading

Oportun Financial (NASDAQ:OPRT) Sets New 12-Month High After Better-Than-Expected Earnings

Big Tech’s $500 billion spending spree leaves a lot less for shareholders

ConocoPhillips Q3 preview: High expectations as upstream focus drives growth

Democrats win control of Congress as voters rebuke Trump agenda

Treasury yields fall after Democrats win House and Senate majorities

Best Stocks Under $5